A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
Clinical trial NCT01404169 · COMPLETED
Trial details
- NCT number
- NCT01404169
- Sponsor
- Eisai Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2014-07-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.